Wolters Kluwer N.V.
Wolters Kluwer is a global leader in professional information, software solutions, and services, with a significant presence in the healthcare sector through its clinical effectiveness division. In the Infection Surveillance Solutions market, the company’s flagship offering is the Sentri7 Clinical Surveillance Suite, which includes Sentri7 Infection Prevention. This solution is recognized as a Best in KLAS product, specializing in real-time, adaptive surveillance. Sentri7 integrates directly with a healthcare facility’s Electronic Health Record (EHR) system to continuously monitor clinical data and automatically flag high-risk patients and potential Healthcare-Acquired Infections (HAIs) or communicable diseases. By providing automated flagging, rule-based alerts, and sophisticated analytics, Sentri7 helps Infection Prevention teams prioritize their efforts, manage multi-drug resistant organisms, and streamline compliance with reporting protocols like the National Healthcare Safety Network (NHSN). This approach shifts the workflow from reactive chart-digging to proactive, data-driven intervention, ultimately improving patient outcomes and reducing costs across health systems.
Latest Market Research Report on Infection Surveillance Solutions Download PDF Brochure Now
Becton, Dickinson and Company (BD)
Becton, Dickinson and Company (BD) is a global medical technology company that provides innovative solutions to advance medical discovery, diagnostics, and the delivery of care. BD is a consistently ranked prominent player in the infection surveillance market, leveraging its extensive portfolio across clinical diagnostics and medication management. The company’s infection surveillance offerings are built on its core capabilities in diagnostics and data analytics, which aim to improve patient safety and clinical outcomes. BD offers software solutions that integrate seamlessly into hospital IT infrastructure to support infection preventionists. This software helps in the proactive monitoring and identification of infections by combining data from laboratory results, EHRs, and other clinical systems. BD’s technology is critical for enhancing surgical performance and patient care by helping facilities implement and monitor adherence to best practices in infection control, including hand hygiene and antimicrobial stewardship, supporting a comprehensive strategy against HAIs.
Premier Inc.
Premier Inc. is a leading healthcare improvement company, operating as a strategic partner to health systems by offering a vast array of solutions in purchasing, analytics, and performance improvement. In the Infection Surveillance Solutions domain, Premier utilizes its robust data and analytics platform, PINC AI, which powers its TheraDoc Infection Control Assistant. This technology is specifically designed to transform complex, disparate clinical data into actionable insights for infection prevention teams. The TheraDoc solution works to streamline infection prevention workflows by providing sophisticated clinical surveillance capabilities, including automated identification of patients at risk for HAIs and other infectious diseases. By integrating with the EHR and other systems, it enables real-time monitoring and cluster surveillance, helping hospitals improve patient safety, ensure quality control, and better manage regulatory compliance. Premier’s focus is on providing a data-driven approach to detect, prevent, and respond to infectious threats more efficiently.
Inovalon (VigiLanz)
Inovalon is a leader in cloud-based software and data-driven solutions for the healthcare industry, and its VigiLanz clinical surveillance platform is a top-tier provider of Infection Surveillance Solutions. VigiLanz Infection Prevention is an advanced, near real-time clinical surveillance software designed for both acute and post-acute care settings. The platform operates 24/7, monitoring live clinical data to detect early warning signs and alert care teams the moment action is required. By employing adaptive surveillance and rule-based alerts, VigiLanz helps prevent harm, improve patient safety, and streamline crucial infection prevention workflows, such as identifying patients for isolation and simplifying CMS compliance. The company offers different product tiers, including Infection Prevention Starter and Pro, to meet varying needs, with a strong focus on turning up-to-the-minute data into immediate, smarter decisions to stay ahead of outbreaks and enhance overall quality of care.
IBM Corporation (Truven Health Analytics/Merative)
IBM Corporation, through its former healthcare data and analytics segment IBM Watson Health, which now operates under the name Merative (and previously Truven Health Analytics), has been a significant player in the infection surveillance market. The company offers advanced solutions that leverage its deep expertise in large-scale data processing, AI, and cloud technology to address public health and hospital-specific infection risks. IBM’s/Merative’s surveillance solutions focus on integrating and analyzing vast amounts of data from Electronic Health Records, lab systems, and other sources to provide predictive analytics and real-time insights into infection trends. The goal is to move beyond simple reporting to proactive identification of high-risk patients and early cluster detection. By applying sophisticated analytical models, these solutions support Antimicrobial Stewardship and Infection Prevention teams in making evidence-based decisions to reduce the incidence of HAIs and optimize care protocols.
Cerner Corporation (Oracle Health)
Cerner Corporation, acquired by Oracle and now known as Oracle Health, is a global leader in Electronic Health Record (EHR) systems, which is the foundational infrastructure for modern Infection Surveillance Solutions. While its core business is the EHR, Cerner’s position in the infection surveillance market is critical because its platforms enable the seamless integration and real-time data feeds necessary for effective surveillance modules. Cerner provides the clinical data backbone that allows specialist surveillance software to function, and it offers its own clinical programs for Infection Prevention. The importance of the company lies in its ability to facilitate “plug-in” surveillance modules that utilize live clinical feeds, reducing the need for manual data entry and enabling rapid, automated flagging of at-risk patients and notifiable conditions. This deep integration is key to accelerating the adoption and effectiveness of digital infection control within hospitals worldwide.
Baxter International Inc.
Baxter International Inc. is a leading global healthcare company that provides a broad portfolio of essential products, including medical devices, pharmaceuticals, and technology for hospitals. Baxter maintains a presence in the Infection Surveillance Solutions segment through its digital health offerings. Notably, Baxter acquired ICNet Systems, Inc., a specialist in infection control software, to strengthen its capabilities in this area. Baxter’s solutions focus on clinical surveillance software designed to capture, manage, and analyze patient-specific data to support infection preventionists. This technology helps hospitals reduce the burden of manual data collection, automate the identification and tracking of healthcare-associated infections (HAIs), and improve regulatory reporting accuracy. By leveraging data-driven insights and providing tools for rapid case finding and outbreak management, Baxter’s platforms enable care teams to deliver more precise and timely interventions to enhance patient safety.
RL Datix Ltd. (RL Solutions)
RL Datix Ltd. is a global leader in governance, risk, and compliance (GRC) software for healthcare, with a strong focus on patient safety. Its RL Solutions portfolio includes specific tools dedicated to Infection Surveillance. The company’s platforms are designed to help healthcare organizations manage patient safety events, and this extends directly into infection control by providing solutions for tracking, analyzing, and reporting infectious disease data. RL Datix’s surveillance tools enable healthcare providers to systematically monitor infection rates, identify trends, and conduct root cause analyses to prevent future occurrences. By centralizing infection data alongside patient safety incidents, the platform helps create a holistic view of clinical risk. The focus is on simplifying the documentation and investigation process for infection prevention teams, allowing them to transform raw data into actionable insights for continuous quality improvement.
bioMérieux, Inc.
bioMérieux is a world leader in in vitro diagnostics, with a core expertise in microbiology and infectious disease management. The company’s role in Infection Surveillance Solutions primarily stems from its ability to provide rapid, accurate diagnostic data and integrate that data into clinical IT systems. While not a pure-play software vendor, bioMérieux’s solutions bridge the gap between the lab and the bedside. The company offers sophisticated platforms and middleware that automate the identification of pathogens and antimicrobial resistance (AMR) profiles. By integrating this essential laboratory data, their systems provide the foundational, real-time microbial information necessary for effective surveillance and Antimicrobial Stewardship Programs. This seamless flow of diagnostic information into hospital systems is critical for timely alerts, outbreak detection, and informing the clinical surveillance software used by infection prevention teams.
Atlas Medical Software (Roper Technologies)
Atlas Medical Software, a part of Roper Technologies, is noted as a prominent player in the global infection surveillance solution market. Atlas specializes in providing data integration and workflow management tools for laboratories and healthcare institutions. Its surveillance solutions are designed to enhance clinical and laboratory communications, which is a vital component of a successful infection prevention program. By focusing on the flow of information, Atlas helps ensure that diagnostic results, especially those related to infectious diseases and culture data, are quickly and reliably delivered and integrated into the overarching surveillance systems. This core capability enables hospitals to rapidly track and report notifiable conditions, manage public health reporting requirements, and provide the accurate, timely data necessary for advanced surveillance software to identify potential outbreaks and guide intervention strategies.
Latest Market Research Report on Infection Surveillance Solutions Download PDF Brochure Now